Beam Therapeutics Inc. (BEAM)
NASDAQ·Healthcare·Biotechnology
$24.40
-5.92%
Mkt Cap $2.67B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
Implied Upside
+113.1%
Consensus $52.00 vs current $24.40
NASDAQ·Healthcare·Biotechnology
$24.40
-5.92%
Mkt Cap $2.67B
Buy
5
Hold
0
Sell
0
Price Target (19 analysts)
$52.00
Range $26.00 – $80.00
+113.1%
Consensus $52.00 vs current $24.40